Skip to main content
Log in

SYSTEMIC LUPUS ERYTHEMATOSUS

Untangling the complexity of medication adherence in SLE

  • News & Views
  • Published:

From Nature Reviews Rheumatology

View current issue Sign up to alerts

Suboptimal medication adherence, a major problem among individuals with systemic lupus erythematosus, is often more pronounced among minority racial groups. As the roots of racial disparities in treatment adherence are beginning to be untangled, the need for multidisciplinary, multilevel approaches to tackle this complex problem is emerging.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1: Factors associated with treatment adherence.

References

  1. Lim, S. S. & Drenkard, C. Epidemiology of lupus: an update. Curr. Opin. Rheumatol. 27, 427–432 (2015).

    Article  Google Scholar 

  2. Lim, S. S. et al. Racial disparities in mortality associated with systemic lupus erythematosus - Fulton and DeKalb counties, Georgia, 2002–2016. MMWR Morb. Mortal. Wkly Rep. 68, 419–422 (2019).

    Article  Google Scholar 

  3. Rhew, E. Y. et al. Differences in subclinical cardiovascular disease between African American and Caucasian women with systemic lupus erythematosus. Transl Res. 153, 51–59 (2009).

    Article  Google Scholar 

  4. Drenkard, C. & Lim, S. S. Update on lupus epidemiology: advancing health disparities research through the study of minority populations. Curr. Opin. Rheumatol. 31, 689–696 (2019).

    Article  CAS  Google Scholar 

  5. Mehat, P. et al. Medication nonadherence in systemic lupus erythematosus: a systematic review. Arthritis Care Res. 69, 1706–1713 (2017).

    Article  Google Scholar 

  6. Sun, K. et al. Racial disparities in medication adherence between African American and Caucasian patients with systemic lupus erythematosus and their associated factors. ACR Open Rheumatol. 2, 430–437 (2020).

    Article  Google Scholar 

  7. World Health Organization. Adherence to long-term therapies: evidence for action. World Health Organization https://www.who.int/chp/knowledge/publications/adherence_full_report.pdf (2003).

  8. Feldman, C. H. et al. Medication nonadherence is associated with increased subsequent acute care utilization among Medicaid beneficiaries with systemic lupus erythematosus. Arthritis Care Res. 67, 1712–1721 (2015).

    Article  CAS  Google Scholar 

  9. Heiman, E. et al. Depressive symptoms are associated with low treatment adherence in African American individuals with systemic lupus erythematosus. J. Clin. Rheumatol. 24, 368–374 (2018).

    Article  Google Scholar 

  10. Feldman, C. H. et al. Dynamic patterns and predictors of hydroxychloroquine nonadherence among Medicaid beneficiaries with systemic lupus erythematosus. Semin. Arthritis Rheum. 48, 205–213 (2018).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cristina Drenkard.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Drenkard, C., Feldman, C.H. Untangling the complexity of medication adherence in SLE. Nat Rev Rheumatol 16, 605–606 (2020). https://doi.org/10.1038/s41584-020-0490-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41584-020-0490-5

  • Springer Nature Limited

Navigation